Akil Jackson

2PUBLICATIONS
8CO-AUTHORS
Haematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 22, 2025
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients.

Kenneth Sooi, Tuan Zea Tan, Jae-Weon Kim

|Dec 01, 2017
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals.

Akil Jackson, Laura Else, Christopher Higgs

Pageof 1

Frequent Collaborators

1 joint publications

Kenneth Sooi

1 joint publications

Tuan Zea Tan

1 joint publications

David Micklem

1 joint publications

David J Pinato